Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia

Study Identifier
199201-007
CT.gov Identifier
NCT02197806
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Eye Care - Other
    • Study Drug
  • AGN-199201
  • AGN-190584
  • AGN-199201 Vehicle
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    40 - 55 Years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    -Presbyopia in each eye that impacts daily activities.
    Exclusion Criteria:
    * Use of any topical ophthalmic medications, including artificial tears * Contact lens use in either eye within 14 days or planned use during the study * History of eye surgery * Diagnosis of any type of glaucoma or ocular hypertension

    Protocol Summary

    A study to evaluate the safety and efficacy of AGN-199201 alone, AGN-190584 alone and concurrent use of AGN-199201 and AGN-190584 in patients with presbyopia (inability to focus for near vision).

    Study Locations

    Location
    Status
    Location
    Newport Beach, California, United States
    Status
    Not applicable